Accessibility: Skip TopNav
IMCIVREE (setmelanotide) injection
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Use in Patients with Bardet-Biedl Syndrome
Format
JPEG
Source
Rhythm Pharmaceuticals, Inc.
Downloads
Original
Large
Medium
Small